Study of cognitive functions , BPSD and burden of care for caregivers in the additional dosage of the memantine hydrochloride for the Alzheimer's disease
Not Applicable
- Conditions
- Alzheimer's disease
- Registration Number
- JPRN-UMIN000020115
- Lead Sponsor
- Faculty of Medicine, University of Miyazaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. dementia patients except Alzheimer's disease 2. the patients who have severe mental disorders 3. the patients having the serious disease including the malignant neoplasm 4. the patients with a history of the hypersensitivity for memantine hydrochloride 5. In addition, the case that a principal investigator or subinvestigator judged to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BPSD Evaluations are performed at baseline (month 0), and at month 3, 6 and 12.
- Secondary Outcome Measures
Name Time Method cognitive function, caregiver's burden Evaluations are performed at baseline (month 0), and at month 3, 6 and 12.